With antimicrobial resistance rising as one of the world's most pressing health threats, the 8th World Congress on Targeting ...

Although the advent and mass production of antibiotics caused a decline in phage therapy, the recent rise in antibiotic resistance has renewed the global interest in this line of treatment. In this ...

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

TAMPA, FL / ACCESS Newswire / April 8, 2025 / Dr. Thomas Rhee, a renowned sports chiropractor and medical innovator, is ...

Here, the authors demonstrate that the type I-B Hachiman system functions as a heterodimeric HamAB complex, in which the helicase and nuclease cooperate to counteract phage infection.